PNTG
The Pennant Group, Inc.Healthcare · $1.4B market cap
Verdict
Share price
$39.24
close of Oct 3, 2026
Fair value
$14.98
Sticker Price
Payback Price
$5.99
buy price
PNTG is Overpriced: at $39.24 it trades 162% above its fair value of $14.98. Its buy price (Payback Price) is $5.99, 85% below today's price. Business quality is solid: 3 of 5 key numbers clear the 10% bar.
How we valued it
Buffett Normalized. A profitable, growing business, so we project its earnings 10 years ahead and work out what that is worth today.
Business quality
3 of 5 clear the 10% bar. What are the Big Five?
Follow PNTG
Get notified when it reaches its buy price of $5.99. Free.
Create a free accountSuperinvestors
1 of the investors we track holds PNTG. In Q2 2026, 1 added. Who we track
Moves in Q2 2026
Insider activity
Since Jul 7, 2026: no open-market purchases, 5 sales worth $532K and 9 other filings (stock awards, tax withholding and similar). Why purchases matter
Sales
Steik Jason Paul
Chief Clinical Officer · 2026-08-06
Sold
$54K
Guerisoli Brent
Chief Executive Officer · 2026-08-06
Sold
$165K
Cheney Kirk Sterling
EVP, GC and Corp Secy · 2026-08-06
Sold
$54K
Guerisoli Brent
Chief Executive Officer · 2026-07-10
Sold
$131K
Guerisoli Brent
Chief Executive Officer · 2026-07-07
Sold
$128K
Other filings
About The Pennant Group, Inc.
The Pennant Group, Inc. is a U.S.-based healthcare provider, delivering a diverse range of services through two core divisions: Home Health and Hospice Services, and Senior Living Services. The company's Home Health segment offers in-home clinical support, encompassing nursing, speech, occupational, and physical therapy, as well as medical social work and home health aide assistance. Its Hospice services focus on…
Medical - Care Facilities
Fair value and Payback Price are estimates from the company's reported financials, not investment advice. Prices as of the close of Oct 3, 2026. How the Payback Price works